Technical Analysis for TELO - Telo Genomics Corp.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 0.205 | -8.89% | -0.020 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Crossed Above 200 DMA | Bullish | -8.89% | |
| 180 Bullish Setup | Bullish Swing Setup | -8.89% | |
| Pocket Pivot | Bullish Swing Setup | -8.89% | |
| Upper Bollinger Band Walk | Strength | -8.89% | |
| Wide Bands | Range Expansion | -8.89% | |
| Overbought Stochastic | Strength | -8.89% |
| Alert | Time |
|---|---|
| Down 2 ATRs | about 10 hours ago |
| Fell Below Previous Day's Low | about 10 hours ago |
| Fell Below 10 DMA | about 10 hours ago |
| Down 1 ATR | about 13 hours ago |
| Down 5% | about 13 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 2024-02-28
Telo Genomics Corp. Description
Telo Genomics Corp, formerly 3D Signatures Inc, is a Canada-based personalized medicine company with a software platform based on the three-dimensional (3D) analysis of telomere organization. Its TeloViewTM platform is designed to inform clinicians and patients with respect to how to personalize treatment and manage an individual’s disease based on their TeloViewTM score. Its software-based technology and prognostic methodology target various diseases that demonstrate genomic instability, including cancer and neurological disorders. It is engaged in developing over five diagnostic and prognostic products for cancers and neurological disorders, including TELO-HL, Telo-MM, Telo-PC, Telo-LC and Telo-AD. Its Telo-PC enables clinicians to identify patient stability during diagnosis, optimize treatment plans and manage to monitor with a non-invasive blood test. Its technology analyzes a specific part of an individual’s deoxyribonucleic acid to determine how a disease progress.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Software Medicine Nature Clinic Disease Cancer Diseases Disorders Cancers Software Platform Telo Neurological Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.335 |
| 52 Week Low | 0.105 |
| Average Volume | 41,182 |
| 200-Day Moving Average | 0.216 |
| 50-Day Moving Average | 0.149 |
| 20-Day Moving Average | 0.153 |
| 10-Day Moving Average | 0.189 |
| Average True Range | 0.018 |
| RSI (14) | 63.77 |
| ADX | 33.46 |
| +DI | 32.369 |
| -DI | 20.206 |
| Chandelier Exit (Long, 3 ATRs) | 0.171 |
| Chandelier Exit (Short, 3 ATRs) | 0.159 |
| Upper Bollinger Bands | 0.237 |
| Lower Bollinger Band | 0.069 |
| Percent B (%b) | 0.81 |
| BandWidth | 109.817 |
| MACD Line | 0.021 |
| MACD Signal Line | 0.012 |
| MACD Histogram | 0.0091 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.273 | ||||
| Resistance 3 (R3) | 0.272 | 0.248 | 0.261 | ||
| Resistance 2 (R2) | 0.248 | 0.231 | 0.249 | 0.257 | |
| Resistance 1 (R1) | 0.227 | 0.221 | 0.215 | 0.228 | 0.254 |
| Pivot Point | 0.203 | 0.203 | 0.198 | 0.204 | 0.203 |
| Support 1 (S1) | 0.182 | 0.186 | 0.170 | 0.183 | 0.156 |
| Support 2 (S2) | 0.158 | 0.176 | 0.159 | 0.153 | |
| Support 3 (S3) | 0.137 | 0.158 | 0.149 | ||
| Support 4 (S4) | 0.138 |
